Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients

Published:2014-10 Issue:10 Volume:99 Page:E1854-E1861
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Kanbay Mehmet,Siriopol Dimitrie,Saglam Mutlu,Kurt Yasemin Gulcan,Gok Mahmut,Cetinkaya Hakki,Karaman Murat,Unal Hilmi Umut,Oguz Yusuf,Sari Sebahattin,Eyileten Tayfun,Goldsmith David,Vural Abdulgaffar,Veisa Gabriel,Covic Adrian,Yilmaz Mahmut Ilker

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm;Cardiovascular Diabetology;2024-08-24

2. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview;Life;2024-03-21

3. Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells;Cardiovascular Diabetology;2023-11-02

4. All the might of the osteocyte: emerging roles in chronic kidney disease;Kidney International;2023-11

5. Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients;Journal of Clinical Medicine;2023-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP